Beyond market averages, investors seeking exceptional growth focus on the art of stock selection. The right picks can significantly contribute to the expansion of your wealth.
Bristol-Myers Squibb Co. (NYSE: BMY) closed the day trading at $52.40 down -0.76% from the previous closing price of $52.80. In other words, the price has decreased by -$0.76 from its previous closing price. On the day, 6.36 million shares were traded. BMY stock price reached its highest trading level at $53.42 during the session, while it also had its lowest trading level at $52.325.
Ratios:
For a better understanding of BMY, let’s look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 15.96 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 8.21. For the most recent quarter (mrq), Quick Ratio is recorded 1.02 and its Current Ratio is at 1.16. In the meantime, Its Debt-to-Equity ratio is 3.17 whereas as Long-Term Debt/Eq ratio is at 2.96.
Redburn Atlantic Downgraded its Buy to Neutral on February 06, 2024, whereas the target price for the stock was revised from $77 to $54.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Dec 05 ’23 when BOERNER CHRISTOPHER S. bought 2,000 shares for $49.78 per share. The transaction valued at 99,560 led to the insider holds 82,672 shares of the business.
BOERNER CHRISTOPHER S. bought 3,071 shares of BMY for $150,049 on Nov 28 ’23. The Chief Executive Officer now owns 79,384 shares after completing the transaction at $48.86 per share. On Nov 20 ’23, another insider, Samuels Theodore R. II, who serves as the Director of the company, bought 8,500 shares for $49.81 each. As a result, the insider paid 423,385 and bolstered with 35,500 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, BMY now has a Market Capitalization of 106235756544 and an Enterprise Value of 153640501248. For the stock, the TTM Price-to-Sale (P/S) ratio is 2.28 while its Price-to-Book (P/B) ratio in mrq is 6.24. Its current Enterprise Value per Revenue stands at 3.303 whereas that against EBITDA is 8.066.
Stock Price History:
Over the past 52 weeks, BMY has reached a high of $57.65, while it has fallen to a 52-week low of $39.35. The 50-Day Moving Average of the stock is 5.54%, while the 200-Day Moving Average is calculated to be 9.63%.
Shares Statistics:
Over the past 3-months, BMY traded about 13.60M shares per day on average, while over the past 10 days, BMY traded about 14323810 shares per day. A total of 2.03B shares are outstanding, with a floating share count of 2.03B. Insiders hold about 0.08% of the company’s shares, while institutions hold 77.24% stake in the company. Shares short for BMY as of 1727654400 were 20033587 with a Short Ratio of 1.47, compared to 1724976000 on 22257179. Therefore, it implies a Short% of Shares Outstanding of 20033587 and a Short% of Float of 0.9900000000000001.
Dividends & Splits
BMY’s forward annual dividend rate is 2.40, up from 2.37 a year ago. Against a Trailing Annual Dividend Yield of 0.04488636The stock’s 5-year Average Dividend Yield is 3.39.